Next-generation condoms – free webinar

Greta Hughson
Published: 02 July 2013

As part of its European HIV prevention work, NAM is collaborating with AVAC to provide a series of webinars (conference calls with accompanying slides) to train and inform prevention advocates and anyone interested in the newest developments in HIV prevention technology.

The sixth webinar is entitled:

Next-generation condoms: European research and perspectives

This webinar will focus on the next generation of male and female condoms being introduced to meet specific HIV prevention needs.

Time and date: 2pm UK time (BST), Tuesday 23 July (3pm CEST)

To register for the webinar and get phone numbers and joining instructions click this link:

https://cc.readytalk.com/cc/s/registrations/new?cid=ozflmhnrw3zl

Speakers and presentations

  • Dr Mags Beksinska, University of the Witwatersrand, on New female and male condoms in the pipeline.
  • Maggie Usher-Patel, WHO/RHR (retired), on Dual protection, quality and performance:  the role of the international community.
  • Dr Bill Potter on The role of manufacturers.
  • Saskia Husken on Universal Access to Female Condoms Joint Programme.

As usual, the presentations will be followed by a question and answer session with our expert speakers. Questions can be submitted in advance to info@avac.org. The webinar will be 90 minutes long and chaired by Rebekah Webb of AVAC. During the event, participants will be encouraged to ask questions via telephone.

This project has been supported via grants from Gilead Sciences Europe Ltd, Merck & Co., Inc. and ViiV Healthcare.

Gilead Sciences Europe Ltd, Merck & Co., Inc. and ViiV Healthcare have provided funding for this project and have had no editorial control over the content of the materials.

Tell us why you visited aidsmap today
minimise

Could you help us by answering three questions on why you’ve visited aidsmap today?

You can close this questionnaire and come back to it later. Just click on the pink circle.

What prompted you to visit aidsmap today?

What exactly are you looking for? What specific questions do you need answered?

Have you found what you were looking for?

close

Thank you for your feedback

Thank you very much for taking time to fill in this questionnaire. NAM really values your feedback. It helps make the information we provide better.

If you have any other comments on the content of this website, we would be interested to hear from you. Please email info@nam.org.uk.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.